Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gabinete Berthier y Martínez is a specialized clinical research organization and medical practice based in Malaga, Spain, focusing on cognitive neurology and neuropsychology. Led by Dr. Marcelo L. Berthier, a prominent expert in language disorders, the entity specializes in the study and treatment of post-stroke aphasia and other cognitive impairments. It has served as a sponsor and clinical site for Phase 3 and Phase 4 trials, notably investigating the use of pharmacological agents like donepezil and memantine in combination with intensive speech-language therapy. The organization operates in close collaboration with the University of Malaga's Centro de Investigaciones Médico-Sanitarias (CIMES). Its research is dedicated to improving communication outcomes and quality of life for patients with chronic brain injuries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gabinete Berthier y Martínez.